Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.58 Analyst target: $110.00 Upside: 2301.75%
Greenland Mines Ltd develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. The company is headquartered in Omaha, Nebraska.
See the full interactive analysis & chart →Informational only — not investment advice.